Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
Rhea-AI Summary
Integra LifeSciences (Nasdaq: IART) announced that CFO Lea Knight will present at the BofA Securities 2026 Health Care Conference on May 12, 2026 at 4:20pm PT. A live webcast will be available on the Integra investor relations site under Events & Presentations.
Positive
- None.
Negative
- None.
News Market Reaction – IART
In the May 8 session, IART gained 2.65%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 05 | Leadership transition | Positive | +24.1% | CEO change with Stuart Essig appointed president and chief executive officer. |
| May 05 | Q1 2026 earnings | Positive | +24.1% | Q1 2026 results with $391.9M revenue and raised adjusted EPS guidance. |
| Apr 20 | Earnings call notice | Neutral | +0.2% | Announcement of date and time for Q1 2026 earnings release and call. |
| Apr 07 | Clinical data update | Positive | +0.2% | New real-world PriMatrix data from 985 cases and a 23-patient burn series. |
| Feb 26 | FY 2025 earnings | Negative | -2.2% | Q4 and 2025 results with GAAP loss driven by $511M goodwill impairment. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has often aligned with price moves, with major leadership and earnings updates coinciding with large positive reactions and weaker results seeing modest downside.
Over the past several months, Integra LifeSciences has reported mixed but improving fundamentals and significant leadership changes. Q4 2025 results on Feb 26 showed a GAAP loss driven by a $511M goodwill impairment and the stock fell 2.24%. Subsequent updates in April and May 2026, including Q1 2026 results with $391.9M revenue and raised EPS guidance, plus the appointment of Stuart Essig as CEO, were followed by a strong 24.13% gain. The current conference appearance follows this period of heightened fundamental and governance activity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the BofA Securities 2026 Health Care Conference on May 12, 2026 at 4:20pm PT.
A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.
About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
Integra LifeSciences Holdings Corporation
